Constantine Chinoporos - 06 Feb 2025 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role
Chief Operating Officer and Chief Business Officer
Signature
/s/ Leslie D. Funtleyder, as Attorney-in-Fact
Issuer symbol
APLT
Transactions as of
06 Feb 2025
Net transactions value
-$17,151
Form type
4
Filing time
07 Feb 2025, 20:30:23 UTC
Previous filing
18 Mar 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Sale $17,151 -28,117 -9.4% $0.6100 271,883 06 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

Remarks:

Chief Operating Officer and Chief Business Officer